KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Non-Current Deffered Revenue (2016 - 2025)

Pacific Biosciences Of California has reported Non-Current Deffered Revenue over the past 15 years, most recently at $3.9 million for Q4 2025.

  • Quarterly results put Non-Current Deffered Revenue at $3.9 million for Q4 2025, down 33.41% from a year ago — trailing twelve months through Dec 2025 was $3.9 million (down 33.41% YoY), and the annual figure for FY2025 was $3.9 million, down 33.41%.
  • Non-Current Deffered Revenue for Q4 2025 was $3.9 million at Pacific Biosciences Of California, down from $4.4 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for PACB hit a ceiling of $25.2 million in Q1 2022 and a floor of $1.8 million in Q3 2022.
  • Median Non-Current Deffered Revenue over the past 5 years was $5.5 million (2023), compared with a mean of $7.0 million.
  • Biggest five-year swings in Non-Current Deffered Revenue: surged 1497.51% in 2021 and later tumbled 92.84% in 2022.
  • Pacific Biosciences Of California's Non-Current Deffered Revenue stood at $25.0 million in 2021, then tumbled by 92.84% to $1.8 million in 2022, then surged by 208.25% to $5.5 million in 2023, then increased by 6.69% to $5.9 million in 2024, then plummeted by 33.41% to $3.9 million in 2025.
  • The last three reported values for Non-Current Deffered Revenue were $3.9 million (Q4 2025), $4.4 million (Q3 2025), and $5.7 million (Q2 2025) per Business Quant data.